Premier Biomedical Inc Receivables Turnover Ratio (BIEI), from the fourth quarter 2019 to the fourth quarter 2018 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Premier Biomedical Inc  (BIEI)
 

Premier Biomedical Inc Accounts Receivables Turnover Ratio from the fourth quarter 2019 to the fourth quarter 2018

Quarterly Results, Trends, Rankings, Statistics


Premier Biomedical Inc's ability to collect accounts receivable sequentially worsen to 5.69, indicating more challenging environment then in the third quarter 2019, but still, it is a far cry from any concerns. Premier Biomedical Inc's Accounts Receivable average collection period in the Dec 31 2019 quarter, has increased to 64 days, from 45 days, in the Sep 30 2019 quarter.

If we take a look into Healthcare sector 512 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2019 from 2682 to 3822.

What is Receivable Turnover Ratio?
What is Premier Biomedical Inc Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BIEI Receivables Turnover Ratio (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter
Y / Y Receivable Change -26.71 % 72.28 % - - 891.03 %
Y / Y Revenue Change -85.63 % -57.87 % -68.78 % -44.82 % -41.32 %
Receivable Turnover Ratio (TTM) 5.69 8.12 11.35 18.89 31.47
BIEI's Total Ranking # 3822 # 2682 # 2754 # 3813 # 3812
Accounts Receivable average collection period days 64 45 32 19 12
Seq. Receivable Change -33.1 % 68.34 % -15.57 % -22.93 % 57.27 %
Seq. Revenue Change -62.31 % -8.19 % -34.21 % -36.87 % 10.47 %


Receivable Turnover Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 43
Healthcare Sector # 513
Overall Market # 3822

Receivable Turnover Ratio Statistics
High Average Low
0.31 0.19 0.1
(Jun 30 2018)   (Dec 31 2019)





BIEI Company Profile • Back to BIEI Efficiency Comparisons • Compare BIEI Receivables Turnover Ratio to its Competitors

Financial Statements
Premier Biomedical Inc's Accounts Receivable $ 0 Millions Visit BIEI's Balance sheet
Premier Biomedical Inc's Sales TTM $ 0 Millions Visit BIEI's Income Statement
Sources of BIEI's Revenues Visit BIEI's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
BIEI's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
BIEI's Growth Rates BIEI's Roa BIEI's Inventory Turnover Ratio BIEI's Dividend Comparisons
BIEI's Profitability Ratios BIEI's Roi BIEI's Asset Turnover Ratio BIEI's Dividend Growth
BIEI's Valuation Ratios BIEI's Roe BIEI's Financial Strength Ratios BIEI's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2019, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Dec 31 2019 Receivable at quarter ending Dec 31 2019
Kyntra Bio Inc   17.06 $ 256.577  Millions$ 15.039  Millions
Invo Fertility Inc   16.94 $ 1.480  Millions$ 0.087  Millions
Imac Holdings Inc   15.91 $ 15.126  Millions$ 0.951  Millions
Cyclo Therapeutics Inc   15.86 $ 1.007  Millions$ 0.064  Millions
Reflect Scientific Inc  15.64 $ 1.609  Millions$ 0.103  Millions
Vbi Vaccines Inc  15.64 $ 2.221  Millions$ 0.142  Millions
Galapagos Nv  15.61 $ 946.383  Millions$ 60.636  Millions
Bellicum Pharmaceuticals Inc   15.48 $ 8.187  Millions$ 0.529  Millions
Mannkind Corporation  15.43 $ 63.038  Millions$ 4.085  Millions
Cv Sciences Inc   15.15 $ 53.696  Millions$ 3.545  Millions
Chemed Corporation  15.09 $ 1,938.555  Millions$ 128.499  Millions
Corcept Therapeutics Inc  15.07 $ 306.486  Millions$ 20.331  Millions
Otonomy Inc   14.72 $ 0.600  Millions$ 0.041  Millions
Neurometrix Inc   14.71 $ 9.273  Millions$ 0.630  Millions
Affimed N v   14.40 $ 23.958  Millions$ 1.664  Millions
Cogent Biosciences Inc   14.04 $ 22.499  Millions$ 1.603  Millions
Musclepharm Corporation  14.02 $ 79.667  Millions$ 5.681  Millions
Taiwan Liposome Company Ltd   13.82 $ 6.992  Millions$ 0.506  Millions
Sanuwave Health Inc   13.69 $ 1.529  Millions$ 0.112  Millions
Titan Medical Inc  13.51 $ 1.136  Millions$ 0.084  Millions
Personalis Inc   13.26 $ 65.207  Millions$ 4.917  Millions
Neuropathix Inc.  13.26 $ 0.165  Millions$ 0.012  Millions
Zymeworks Inc   13.25 $ 29.544  Millions$ 2.230  Millions
Therapeutic Solutions International Inc   13.10 $ 0.027  Millions$ 0.002  Millions
Miragen Therapeutics Inc   12.58 $ 4.461  Millions$ 0.355  Millions
Lifeloc Technologies Inc   12.28 $ 8.752  Millions$ 0.712  Millions
Dermtech Inc   12.25 $ 4.574  Millions$ 0.374  Millions
China Pharma Holdings Inc  12.12 $ 10.924  Millions$ 0.902  Millions
Integrated Biopharma Inc  12.09 $ 53.275  Millions$ 4.408  Millions
Momenta Pharmaceuticals inc   11.91 $ 23.868  Millions$ 2.003  Millions

Date modified: 2026-09-08T15:09:57+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.